TABLE 2.
Characteristic | Value, n (%) | Value for Participants at Inpatient Visit (Expected to Be Fasting), Mean ± SD | Value for Participants at Outpatient Visit (Self-Reported as Fasting), Mean ± SD |
---|---|---|---|
Sex | — | — | |
Male | 123 (42.0) | — | — |
Female | 170 (58.0) | — | — |
Race | — | — | |
African American | 148 (50.5) | — | — |
White | 142 (48.5) | — | — |
Multiple races or other | 3 (1.0) | — | — |
Ethnicity | — | — | |
Hispanic or Latino | 1 (0.3) | — | — |
Age, y | — | 12.47 ± 2.97 | 12.37 ± 3.03 |
BMI | — | 34.34 ± 11.87 | 34.57 ± 11.99 |
BMIz | — | 2.13 ± 0.85 | 2.16 ± 0.84 |
Serum glucose, mg/dL | — | 89.5 ± 15.6 | 88.1 ± 12.2 |
Serum insulin, µU/mL | — | 21.2 ± 17.6 | 22.9 ± 18.6 |
Serum FFA, mEq/mL | — | 787.5 ± 454.8 | 630.6 ± 241.0 |
Average days between visits: 38.1 ± 37.5. Serum glucose was available in 287 participants studied as inpatients and 293 participants studied as outpatients. Serum insulin was available in 288 participants studied as inpatients and 287 participants studied as outpatients. —, not applicable